From BioPolicyWiki
Revision as of 13:38, 25 August 2008 by Jreynolds (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Region Europe
Population 10,584,534
GDP (millions USD) 453,636
National Policies
Eggs for assisted reproduction commercial prohibited
Eggs for research commercial prohibited
Inheritable genetic modification PROHIBITED
Preimplantation genetic diagnosis social uses prohibited
Reproductive cloning PROHIBITED
Research cloning regulated
Sex selection "social uses prohibited" is not in the list of possible values (?, PROHIBITED, regulated, Social uses prohibited, no policy) for this property.
Surrogacy no policy
International Agreements
1997 COE Biomedicine Convention not signed
1998 COE Cloning Convention not signed
2005 UN Cloning Vote no
2005 UNESCO Sports Doping Convention RATIFIED
2007 Treaty of Lisbon signed


Key laws and policies

Foundational values

The Law on Research into Embryos law expresses a belief in the importance of freedom of research and the acceptance of ethical pluralism in society.

Prohibited practices

The Law on Research into Embryos prohibits

  • reproductive cloning
  • conducting research or treatment for eugenic purposes, i.e. PGD or genetic modification for enhancement or for social purposes
  • sex selection for nonmedical purposes
  • using embryos, gametes and embryonic stem cells for commercial purposes
  • placing human embryos in animals
  • creating chimeras or hybrids
  • placing embryos on which research has been conducted in humans, except when the research had a therapeutic benefit for the embryo itself or when it concerns an observation method that does not harm the embryo’s integrity

Permitted and regulated practices

The Law on Research into Embryos appears to affirm all types of research directed at therapeutic purposes and increased medical knowledge. Implicitly, the creation of embryos for research is also allowed.

Couples seeking PGD must be seen by psychologists and counseled regarding the welfare of the future child, the family context, and parenting abilities before the procedure is approved.

Research on embryos in vitro is allowed if

  1. the research has a therapeutic purpose or contributes to a better knowledge about fertility, infertility, organ and tissue transplantation, prevention or treatment of diseases
  2. the research is founded on the most recent scientific findings and is conform the requirements of correct scientific methodology
  3. the research is conducted in a licensed laboratory that is linked to an academic program for assisted reproduction or human genetics and is performed in appropriate technical and material conditions
  4. the research is conducted under the supervision of a specialist or a qualified person
  5. the research is performed on embryos during the first 14 days of development, the period of freezing not included
  6. There is no other research method that is equally efficient

There are no policies concerning surrogacy.[3][4]

Regulatory activities

Assisted Reproductive Technology centers must obtain a license to practice, provide annual reports and work with one of eight human genetic centers established at the eight medical faculties in Belgium. The centers decide autonomously for which conditions and therapeutic purposes (e.g. HLA-typing) they will offer PGD and to whom. [5]

The Law on Research into Embryos requires that embryo research be approved by a local ethics committee of the academic institute and the Federal Commission for medical and scientific research on embryos in vitro. The Commission rules with a two-thirds majority.

Every embryo researcher sends a report on the progress of his/her research to the Commission. This report includes:

  • the purpose, methodology and time period of the research
  • the manner in which the provisions of the law were respected
  • the advice of the local ethics committee
  • the progress of the research

The Commission also collects and centralizes information on the different projects on embryos in vitro, and issues recommendations for future legislative initiatives or other measures;

Accountability and governance

The Law on Research into Embryos requires that the Federal Commission for medical and scientific research on embryos in vitro reports to the legislative chambers.


Belgium was one of the last countries in the European Union to regulate PGD and embryo research by law. Until 1999, PGD was permitted unregulated without license.

External links


  1. G. Pennings, "New Belgian Law on Research on Human Embryos," Journal of Assisted Reproduction and Genetics, Vol. 20, No. 8, August 2003 [subscription required]
  2. G. Pennings, "Belgian law on medically assisted reproduction and the disposition of supernumerary embryos and gametes," European Journal of Health Law, Vol. 14, No. 3, November 2007 [subscription required]
  3. Dolores Dooley and Panagiota Dalla-Vorgia, Ethics of New Reproductive Technologies: Cases and Questions Berghahn Books (2003) p. 66
  4. I. Stuyver, K. Denys, P. De Sutter, J. Gerris, M. Dhont, "A three-year experience with gestational surrogacy: an evaluation of medical, ethical and legal aspects," Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France (July 1–4 , 2007), p. i198
  5. Dr. Irmgard Nippert, "PGD in Belgium, France and the United Kingdom," English-language summary of Präimplantationsdiagnostik: ein Ländervergleich, Friedrich-Ebert-Stiftung, Berlin, 2006